Introducing the Anti-Borreliella burgdorferi ospA Antibody (SAA2243) – your ultimate solution for targeted detection and inhibition of Lyme disease-causing bacteria.
This highly specific antibody is designed to target the outer surface protein A (ospA) of Borreliella burgdorferi, the main causative agent of Lyme disease. Through its unique binding affinity, SAA2243 effectively blocks the activity of ospA, preventing the bacteria from attaching to host cells and causing infection.
With its exceptional specificity and sensitivity, SAA2243 is a valuable tool for researchers studying the pathogenesis of Lyme disease. It can be used for various applications, including Western blot, ELISA, and immunohistochemistry, providing reliable and reproducible results.
In addition to its research applications, SAA2243 has also shown promising results in experimental use cases. In a recent study, the antibody was able to significantly reduce the bacterial load and inflammation in mice infected with Borreliella burgdorferi. This highlights its potential for therapeutic use in treating Lyme disease.
SAA2243 is produced using advanced biotechnology techniques, ensuring high purity and consistency in every batch. It is also available in a variety of sizes to suit your specific research needs.
In summary, the Anti-Borreliella burgdorferi ospA Antibody (SAA2243) is a powerful tool for detecting and inhibiting the activity of Lyme disease-causing bacteria. Its high specificity, versatility, and potential therapeutic applications make it a valuable addition to any biotech laboratory. Take the first step in advancing your Lyme disease research by incorporating SAA2243 into your experiments today.
There are no reviews yet.